These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients]. Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y. Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562 [Abstract] [Full Text] [Related]
6. [Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL]. Li J, Zhang ZB, Liu ZR, Yang M, Nie YX, Wu MM. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1011-1015. PubMed ID: 30111399 [Abstract] [Full Text] [Related]
7. Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Lim SN, Joo YD, Lee KH, Kim DY, Lee JH, Lee JH, Chi HS, Yun SC, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo HM, Bae SH, Hyun MS, Kim MK, Kim HJ, Yang DH, Eom HS, Lee GW, Jung CW, Won JH, Kim H, Lee JH, Shin HJ, Jang DY. Am J Hematol; 2015 Nov; 90(11):1013-20. PubMed ID: 26228525 [Abstract] [Full Text] [Related]
8. Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation. Hu M, Wang H, Wang L, Yang M, Lou Y, Jin J. Medicine (Baltimore); 2018 Jul; 97(28):e11374. PubMed ID: 29995776 [Abstract] [Full Text] [Related]
10. DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study. Dudler C, Bargetzi M, Tichelli A, Gratwohl A, Passweg JR, Wernli M. Eur J Haematol; 2009 Dec 01; 83(6):512-8. PubMed ID: 19614953 [Abstract] [Full Text] [Related]
11. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia]. Cheng Z, Zhao L, Chen G, Wu D, Qiu H, Tang X, Fu C, Jin Z, Chen F, Xue S, Sun A. Zhonghua Xue Ye Xue Za Zhi; 2014 Feb 01; 35(2):114-9. PubMed ID: 24606651 [Abstract] [Full Text] [Related]
12. High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia. Offidani M, Corvatta L, Centurioni R, Leoni F, Malerba L, Mele A, Marconi M, Scortechini A, Masia MC, Leoni P. Hematol J; 2003 Feb 01; 4(1):47-53. PubMed ID: 12692520 [Abstract] [Full Text] [Related]
14. [Long-term destiny of adolescents and young adults with de novo acute lymphoblastic leukemia treated with a pediatric protocol type]. López-Hernández MA, Alvarado-Ibarra M, Álvarez-Veral JL, Ortiz-Zepeda M, Guajardo-Leal ML, Cota-Range X. Gac Med Mex; 2016 Feb 01; 152(5):439-443. PubMed ID: 27792701 [Abstract] [Full Text] [Related]
15. Prognostic factors in adolescent and adult patients with acute lymphoblastic leukemia with two protocols of chemotherapy: a cross-sectional study. Pinheiro Junior ED, Pracchia LF, Beitler de Mauriño B, Martinez GA, Dorlhiac-Llacer PE, Medina AB, Velloso ED. Clin Lymphoma Myeloma Leuk; 2015 Jan 01; 15(1):e7-e14. PubMed ID: 25130688 [Abstract] [Full Text] [Related]
16. [Outcomes of younger than 60 years old adults with Ph/BCR-ABL positive acute lymphoblastic leukemia: a single center clinical trial of BDH ALL 2000/02]. Zhang YR, Wang TY, Zou DH, Sui WW, Li ZJ, Xu Y, Fu MW, Zhao YZ, Qi JY, Wang JX, Mi YC, Qiu LG. Zhonghua Xue Ye Xue Za Zhi; 2013 Jun 01; 34(6):493-7. PubMed ID: 23827104 [Abstract] [Full Text] [Related]